Nav: Home

New stem cell pathway indicates route to much higher yields in maize, staple crops

May 16, 2016

Cold Spring Harbor, NY - Biologists at Cold Spring Harbor Laboratory (CSHL) have made an important discovery that helps explain how plants regulate the proliferation of their stem cells. The discovery has near-term implications for increasing the yield of maize and many other staple crops, perhaps by as much as 50%.

The newly discovered regulatory pathway is notable in that it channels signals emanating from a plant's extremities -- emerging young leaves called primordia -- to the stem cell niche, called the meristem, located at the plant's growing tip.

Plant biologists have long known of another pathway, called the CLAVATA-WUSCHEL pathway, that regulates stem cell proliferation from within a portion of the meristem itself, called the organizing center (OC). In this canonical pathway, "the receptor and ligand are [both] expressed in the stem cells, which send signals down to the cells just below, in the OC," explains CSHL Professor David Jackson, who led the team that found the new pathway.

WUSCHEL is a transcription factor that alters gene expression, and in so doing promotes the proliferation of stem cells, which are totipotent -- capable in plants, as in humans, of developing into cells of any type. In the canonical CLAVATA-WUSCHEL pathway, stem cells send back to the OC a negative signal, repressing the signal for proliferation.

A similar feedback is established in the newly discovered pathway, although its signal begins in leaves. Having a signal coming from the leaves is new, and exciting because it could act as a kind of environmental sensor, telling totipotent stem cells in the meristem to stop proliferating -- a brake, applied from the older, more developed parts of the plant, for example in response to environmental cues such as available light, nutrients or moisture.

Jackson and colleagues identified the receptor for these "braking signals from the leaves" in cells in the lower part of the meristem. They named the receptor FEA3. They also discovered the ligand that interacts with the receptor, a protein fragment called FCP1.

In a highly consequential extension of the work of discovery, Jackson's team studied maize plants in which FEA3 - the receptor for the signal from the leaves - was dysfunctional, owing to a variety of mutations in the FEA3 gene.

When FEA3 receptors in the meristem are not able to function at all, "it is as if they are blind to FCP1," says Jackson. The inhibitory signal FCP1 sends from the leaves to the meristem is not received, and stem cells proliferate wildly. The plant makes far too many stem cells, and they give rise to too many new seeds -- seeds the plant cannot support with available resources (light, moisture, nutrients). In such FEA3 mutant plants, maize ears develop that exhibit a quality called fasciation; from their greatly extended meristems, too many baby kernels are generated, which form misshapen, and ultimately yield-poor ears.

But when Jackson's team performed a genetic trick, growing plants with so called "weak alleles" of the FEA3 gene, function of the FEA3 receptor was only mildly impaired. This moderate failure of the braking signal from outside of the meristem gave rise to a modest, manageable increase in stem cells, and to ears that were significantly larger than ears in wild-type plants.

These ears, the product of maize plants grown from weak alleles of FEA3, had more rows of kernels, and up to 50% higher yield overall than wild-type plants.

Because the newly discovered FAE3-FCP1 pathway is highly conserved across the plant kingdom, the discovery by Jackson's team holds the prospect of translating into significant increases in yield in all the major staple crops.

Before such translational work can proceed, Jackson and colleagues plan to test the newly discovered FEA3 alleles in elite varieties of maize and other crops in agricultural trials.

This work was supported by the NSF Plant Genome Research Program; Dupont Pioneer; the Gatsby Charitable Foundation; Swedish Research Council; Rural Development Administration, Republic of Korea.
-end-
"Signaling from organ primordial regulates stem cell proliferation and maize yields, via the FASCIATED EAR3 receptor-like protein" appears online in Nature Genetics on Monday, May 16, 2016. The authors are: Byoung Il Je, Jeremy Gruel, Young Koung Lee, Peter Bommert, Edgar Demesa Arevalo, Andrea L. Eveland, Qingyu Wu, Alexander Goldshmidt, Robert Meeley, Madelaine Bartlett, Mai Komatsu, Hajime Sakai, Henrik Jönsson and David Jackson. The paper can be obtained at: http://www.nature.com/ng/index.html

About Cold Spring Harbor Laboratory



Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. The Meetings & Courses Program hosts more than 12,000 scientists from around the world each year on its campuses in Long Island and in Suzhou, China. The Laboratory's education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers. For more information, visit http://www.cshl.edu.

Cold Spring Harbor Laboratory

Related Stem Cells Articles:

A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
New research finds novel method for generating airway cells from stem cells
Researchers have developed a new approach for growing and studying cells they hope one day will lead to curing lung diseases such as cystic fibrosis through 'personalized medicine.'
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
Mutations in bone cells can drive leukemia in neighboring stem cells
DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Stem cells from diabetic patients coaxed to become insulin-secreting cells
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St.

Related Stem Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...